nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—NR3C1—epilepsy syndrome	0.219	0.597	CbGaD
Ciclesonide—CES1—Rufinamide—epilepsy syndrome	0.198	0.472	CbGbCtD
Ciclesonide—CYP2D6—epilepsy syndrome	0.148	0.403	CbGaD
Ciclesonide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0181	0.0432	CbGbCtD
Ciclesonide—CYP3A4—Felbamate—epilepsy syndrome	0.0169	0.0402	CbGbCtD
Ciclesonide—CYP3A4—Trimethadione—epilepsy syndrome	0.0169	0.0402	CbGbCtD
Ciclesonide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0158	0.0378	CbGbCtD
Ciclesonide—CYP2D6—Propofol—epilepsy syndrome	0.015	0.0357	CbGbCtD
Ciclesonide—CYP3A4—Clonazepam—epilepsy syndrome	0.0143	0.0342	CbGbCtD
Ciclesonide—CYP3A4—Clobazam—epilepsy syndrome	0.0137	0.0327	CbGbCtD
Ciclesonide—CYP3A4—Rufinamide—epilepsy syndrome	0.0117	0.0278	CbGbCtD
Ciclesonide—CYP3A4—Carbamazepine—epilepsy syndrome	0.0114	0.0271	CbGbCtD
Ciclesonide—CYP3A4—Primidone—epilepsy syndrome	0.0106	0.0253	CbGbCtD
Ciclesonide—CYP3A4—Phenytoin—epilepsy syndrome	0.0102	0.0243	CbGbCtD
Ciclesonide—CYP3A4—Propofol—epilepsy syndrome	0.00952	0.0227	CbGbCtD
Ciclesonide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0091	0.0217	CbGbCtD
Ciclesonide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0091	0.0217	CbGbCtD
Ciclesonide—CYP3A4—Midazolam—epilepsy syndrome	0.00897	0.0214	CbGbCtD
Ciclesonide—CYP3A4—Diazepam—epilepsy syndrome	0.00863	0.0206	CbGbCtD
Ciclesonide—CYP3A4—Zonisamide—epilepsy syndrome	0.00842	0.0201	CbGbCtD
Ciclesonide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0068	0.0162	CbGbCtD
Ciclesonide—CYP3A4—Topiramate—epilepsy syndrome	0.00614	0.0146	CbGbCtD
Ciclesonide—SERPINA6—hindbrain—epilepsy syndrome	0.00111	0.136	CbGeAlD
Ciclesonide—NR3C1—hindbrain—epilepsy syndrome	0.000485	0.0597	CbGeAlD
Ciclesonide—CYP2D6—hindbrain—epilepsy syndrome	0.000361	0.0444	CbGeAlD
Ciclesonide—CES1—head—epilepsy syndrome	0.000351	0.0432	CbGeAlD
Ciclesonide—SERPINA6—head—epilepsy syndrome	0.000351	0.0432	CbGeAlD
Ciclesonide—CES1—nervous system—epilepsy syndrome	0.000333	0.041	CbGeAlD
Ciclesonide—SERPINA6—nervous system—epilepsy syndrome	0.000333	0.0409	CbGeAlD
Ciclesonide—CES1—central nervous system—epilepsy syndrome	0.000321	0.0394	CbGeAlD
Ciclesonide—SERPINA6—central nervous system—epilepsy syndrome	0.00032	0.0394	CbGeAlD
Ciclesonide—SERPINA6—cerebellum—epilepsy syndrome	0.000313	0.0385	CbGeAlD
Ciclesonide—Prednisone—SLCO1A2—epilepsy syndrome	0.000285	0.0703	CrCbGaD
Ciclesonide—NR3C1—brainstem—epilepsy syndrome	0.000278	0.0342	CbGeAlD
Ciclesonide—NR3C1—forebrain—epilepsy syndrome	0.000268	0.033	CbGeAlD
Ciclesonide—Prednisolone—SLCO1A2—epilepsy syndrome	0.000263	0.0648	CrCbGaD
Ciclesonide—CES1—brain—epilepsy syndrome	0.000255	0.0313	CbGeAlD
Ciclesonide—SERPINA6—brain—epilepsy syndrome	0.000254	0.0313	CbGeAlD
Ciclesonide—NR3C1—telencephalon—epilepsy syndrome	0.000247	0.0304	CbGeAlD
Ciclesonide—Prednicarbate—NR3C1—epilepsy syndrome	0.000239	0.059	CrCbGaD
Ciclesonide—Desonide—NR3C1—epilepsy syndrome	0.000226	0.0558	CrCbGaD
Ciclesonide—Loteprednol—NR3C1—epilepsy syndrome	0.000218	0.0538	CrCbGaD
Ciclesonide—CYP2D6—brainstem—epilepsy syndrome	0.000207	0.0255	CbGeAlD
Ciclesonide—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000201	0.0495	CrCbGaD
Ciclesonide—CYP2D6—forebrain—epilepsy syndrome	0.0002	0.0246	CbGeAlD
Ciclesonide—NR3C1—medulla oblongata—epilepsy syndrome	0.000194	0.0239	CbGeAlD
Ciclesonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000193	0.0477	CrCbGaD
Ciclesonide—Hydrocortamate—NR3C1—epilepsy syndrome	0.000187	0.0461	CrCbGaD
Ciclesonide—CYP2D6—telencephalon—epilepsy syndrome	0.000184	0.0226	CbGeAlD
Ciclesonide—NR3C1—midbrain—epilepsy syndrome	0.000177	0.0218	CbGeAlD
Ciclesonide—Amcinonide—NR3C1—epilepsy syndrome	0.000174	0.0429	CrCbGaD
Ciclesonide—Budesonide—NR3C1—epilepsy syndrome	0.000174	0.0429	CrCbGaD
Ciclesonide—NR3C1—spinal cord—epilepsy syndrome	0.000173	0.0213	CbGeAlD
Ciclesonide—Rimexolone—NR3C1—epilepsy syndrome	0.000163	0.0403	CrCbGaD
Ciclesonide—Fluocinonide—NR3C1—epilepsy syndrome	0.000154	0.038	CrCbGaD
Ciclesonide—Beclomethasone—NR3C1—epilepsy syndrome	0.000154	0.038	CrCbGaD
Ciclesonide—NR3C1—head—epilepsy syndrome	0.000154	0.0189	CbGeAlD
Ciclesonide—Alclometasone—NR3C1—epilepsy syndrome	0.00015	0.0369	CrCbGaD
Ciclesonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000146	0.036	CrCbGaD
Ciclesonide—Flunisolide—NR3C1—epilepsy syndrome	0.000146	0.036	CrCbGaD
Ciclesonide—NR3C1—nervous system—epilepsy syndrome	0.000146	0.0179	CbGeAlD
Ciclesonide—Paramethasone—NR3C1—epilepsy syndrome	0.000144	0.0355	CrCbGaD
Ciclesonide—NR3C1—central nervous system—epilepsy syndrome	0.00014	0.0173	CbGeAlD
Ciclesonide—NR3C1—cerebellum—epilepsy syndrome	0.000137	0.0169	CbGeAlD
Ciclesonide—Methylprednisolone—NR3C1—epilepsy syndrome	0.000136	0.0335	CrCbGaD
Ciclesonide—CES1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000131	0.00658	CbGpPWpGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—epilepsy syndrome	0.000127	0.00641	CbGpPWpGaD
Ciclesonide—Dry mouth—Lamotrigine—epilepsy syndrome	0.000127	0.000701	CcSEcCtD
Ciclesonide—Dyspepsia—Felbamate—epilepsy syndrome	0.000126	0.000699	CcSEcCtD
Ciclesonide—Rash—Clobazam—epilepsy syndrome	0.000126	0.000699	CcSEcCtD
Ciclesonide—Dermatitis—Clobazam—epilepsy syndrome	0.000126	0.000698	CcSEcCtD
Ciclesonide—Haemoglobin—Pregabalin—epilepsy syndrome	0.000126	0.000698	CcSEcCtD
Ciclesonide—Rhinitis—Pregabalin—epilepsy syndrome	0.000126	0.000696	CcSEcCtD
Ciclesonide—Haemorrhage—Pregabalin—epilepsy syndrome	0.000126	0.000695	CcSEcCtD
Ciclesonide—Headache—Clobazam—epilepsy syndrome	0.000126	0.000694	CcSEcCtD
Ciclesonide—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000125	0.000694	CcSEcCtD
Ciclesonide—Dyspnoea—Zonisamide—epilepsy syndrome	0.000125	0.000693	CcSEcCtD
Ciclesonide—Nasopharyngitis—Topiramate—epilepsy syndrome	0.000125	0.000693	CcSEcCtD
Ciclesonide—Mediastinal disorder—Valproic Acid—epilepsy syndrome	0.000125	0.000692	CcSEcCtD
Ciclesonide—Conjunctivitis—Gabapentin—epilepsy syndrome	0.000125	0.00069	CcSEcCtD
Ciclesonide—Urinary tract infection—Gabapentin—epilepsy syndrome	0.000125	0.00069	CcSEcCtD
Ciclesonide—Pharyngitis—Pregabalin—epilepsy syndrome	0.000125	0.000689	CcSEcCtD
Ciclesonide—Fatigue—Felbamate—epilepsy syndrome	0.000124	0.000685	CcSEcCtD
Ciclesonide—Dyspepsia—Zonisamide—epilepsy syndrome	0.000124	0.000685	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Topiramate—epilepsy syndrome	0.000123	0.000683	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000123	0.000683	CcSEcCtD
Ciclesonide—Infection—Lamotrigine—epilepsy syndrome	0.000123	0.000682	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000123	0.00619	CbGpPWpGaD
Ciclesonide—Urticaria—Fosphenytoin—epilepsy syndrome	0.000123	0.00068	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000123	0.000678	CcSEcCtD
Ciclesonide—Nausea—Lacosamide—epilepsy syndrome	0.000123	0.000678	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000122	0.000675	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000121	0.000671	CcSEcCtD
Ciclesonide—Fatigue—Zonisamide—epilepsy syndrome	0.000121	0.000671	CcSEcCtD
Ciclesonide—Epistaxis—Gabapentin—epilepsy syndrome	0.000121	0.000669	CcSEcCtD
Ciclesonide—Dyspnoea—Clonazepam—epilepsy syndrome	0.000121	0.000668	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—VDR—epilepsy syndrome	0.000121	0.00606	CbGpPWpGaD
Ciclesonide—Sinusitis—Gabapentin—epilepsy syndrome	0.00012	0.000666	CcSEcCtD
Ciclesonide—Dyspnoea—Phenytoin—epilepsy syndrome	0.00012	0.000664	CcSEcCtD
Ciclesonide—Urticaria—Vigabatrin—epilepsy syndrome	0.00012	0.000662	CcSEcCtD
Ciclesonide—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000119	0.00066	CcSEcCtD
Ciclesonide—Dyspepsia—Clonazepam—epilepsy syndrome	0.000119	0.00066	CcSEcCtD
Ciclesonide—Nausea—Clobazam—epilepsy syndrome	0.000119	0.000658	CcSEcCtD
Ciclesonide—Asthenia—Propofol—epilepsy syndrome	0.000119	0.000658	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—CYP2C19—epilepsy syndrome	0.000119	0.00596	CbGpPWpGaD
Ciclesonide—Dyspepsia—Phenytoin—epilepsy syndrome	0.000118	0.000655	CcSEcCtD
Ciclesonide—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000118	0.000655	CcSEcCtD
Ciclesonide—Dizziness—Acetazolamide—epilepsy syndrome	0.000118	0.000653	CcSEcCtD
Ciclesonide—CYP3A4—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000118	0.00594	CbGpPWpGaD
Ciclesonide—Urticaria—Diazepam—epilepsy syndrome	0.000118	0.000652	CcSEcCtD
Ciclesonide—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000118	0.000652	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000117	0.000647	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000117	0.000647	CcSEcCtD
Ciclesonide—Back pain—Valproic Acid—epilepsy syndrome	0.000117	0.000647	CcSEcCtD
Ciclesonide—Fatigue—Clonazepam—epilepsy syndrome	0.000117	0.000646	CcSEcCtD
Ciclesonide—Asthenia—Midazolam—epilepsy syndrome	0.000116	0.000644	CcSEcCtD
Ciclesonide—Bronchitis—Topiramate—epilepsy syndrome	0.000116	0.000644	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000116	0.000643	CcSEcCtD
Ciclesonide—Fatigue—Phenytoin—epilepsy syndrome	0.000116	0.000642	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000116	0.000639	CcSEcCtD
Ciclesonide—Fatigue—Oxcarbazepine—epilepsy syndrome	0.000115	0.000638	CcSEcCtD
Ciclesonide—Rhinitis—Gabapentin—epilepsy syndrome	0.000115	0.000638	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK10—epilepsy syndrome	0.000115	0.0058	CbGpPWpGaD
Ciclesonide—Haemorrhage—Gabapentin—epilepsy syndrome	0.000115	0.000637	CcSEcCtD
Ciclesonide—Asthenia—Levetiracetam—epilepsy syndrome	0.000115	0.000636	CcSEcCtD
Ciclesonide—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000115	0.000634	CcSEcCtD
Ciclesonide—CYP2D6—head—epilepsy syndrome	0.000114	0.0141	CbGeAlD
Ciclesonide—Pharyngitis—Gabapentin—epilepsy syndrome	0.000114	0.000632	CcSEcCtD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—epilepsy syndrome	0.000114	0.00574	CbGpPWpGaD
Ciclesonide—Urticaria—Felbamate—epilepsy syndrome	0.000114	0.000631	CcSEcCtD
Ciclesonide—Immune system disorder—Pregabalin—epilepsy syndrome	0.000113	0.000627	CcSEcCtD
Ciclesonide—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000113	0.000626	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000113	0.000626	CcSEcCtD
Ciclesonide—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000113	0.000626	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000112	0.000622	CcSEcCtD
Ciclesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.000112	0.00563	CbGpPWpGaD
Ciclesonide—Headache—Acetazolamide—epilepsy syndrome	0.000112	0.000619	CcSEcCtD
Ciclesonide—Urticaria—Zonisamide—epilepsy syndrome	0.000112	0.000618	CcSEcCtD
Ciclesonide—NR3C1—brain—epilepsy syndrome	0.000111	0.0137	CbGeAlD
Ciclesonide—Asthenia—Fosphenytoin—epilepsy syndrome	0.000111	0.000614	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000111	0.000614	CcSEcCtD
Ciclesonide—Fatigue—Carbamazepine—epilepsy syndrome	0.000111	0.000613	CcSEcCtD
Ciclesonide—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000111	0.000612	CcSEcCtD
Ciclesonide—Angioedema—Valproic Acid—epilepsy syndrome	0.00011	0.000611	CcSEcCtD
Ciclesonide—CYP3A4—nervous system—epilepsy syndrome	0.00011	0.0136	CbGeAlD
Ciclesonide—Weight increased—Topiramate—epilepsy syndrome	0.00011	0.000609	CcSEcCtD
Ciclesonide—Dizziness—Propofol—epilepsy syndrome	0.00011	0.000607	CcSEcCtD
Ciclesonide—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000109	0.000605	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—RET—epilepsy syndrome	0.000109	0.00548	CbGpPWpGaD
Ciclesonide—Pneumonia—Topiramate—epilepsy syndrome	0.000109	0.0006	CcSEcCtD
Ciclesonide—CYP2D6—nervous system—epilepsy syndrome	0.000108	0.0133	CbGeAlD
Ciclesonide—Asthenia—Vigabatrin—epilepsy syndrome	0.000108	0.000598	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—MIF—epilepsy syndrome	0.000108	0.00544	CbGpPWpGaD
Ciclesonide—Infestation—Topiramate—epilepsy syndrome	0.000108	0.000597	CcSEcCtD
Ciclesonide—Infestation NOS—Topiramate—epilepsy syndrome	0.000108	0.000597	CcSEcCtD
Ciclesonide—Urticaria—Clonazepam—epilepsy syndrome	0.000108	0.000595	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—HMOX1—epilepsy syndrome	0.000108	0.00541	CbGpPWpGaD
Ciclesonide—Dizziness—Midazolam—epilepsy syndrome	0.000107	0.000594	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000107	0.000593	CcSEcCtD
Ciclesonide—Fatigue—Lamotrigine—epilepsy syndrome	0.000107	0.000592	CcSEcCtD
Ciclesonide—Dysgeusia—Pregabalin—epilepsy syndrome	0.000107	0.000592	CcSEcCtD
Ciclesonide—Urticaria—Phenytoin—epilepsy syndrome	0.000107	0.000591	CcSEcCtD
Ciclesonide—Palpitations—Valproic Acid—epilepsy syndrome	0.000107	0.000591	CcSEcCtD
Ciclesonide—Asthenia—Diazepam—epilepsy syndrome	0.000106	0.000589	CcSEcCtD
Ciclesonide—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000106	0.000588	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MAP2—epilepsy syndrome	0.000106	0.00534	CbGpPWpGaD
Ciclesonide—CYP3A4—central nervous system—epilepsy syndrome	0.000106	0.013	CbGeAlD
Ciclesonide—Nausea—Acetazolamide—epilepsy syndrome	0.000106	0.000587	CcSEcCtD
Ciclesonide—Dizziness—Levetiracetam—epilepsy syndrome	0.000106	0.000586	CcSEcCtD
Ciclesonide—Back pain—Pregabalin—epilepsy syndrome	0.000106	0.000585	CcSEcCtD
Ciclesonide—Cough—Valproic Acid—epilepsy syndrome	0.000106	0.000584	CcSEcCtD
Ciclesonide—Conjunctivitis—Topiramate—epilepsy syndrome	0.000105	0.00058	CcSEcCtD
Ciclesonide—Urinary tract infection—Topiramate—epilepsy syndrome	0.000105	0.00058	CcSEcCtD
Ciclesonide—Rash—Propofol—epilepsy syndrome	0.000105	0.000578	CcSEcCtD
Ciclesonide—Dermatitis—Propofol—epilepsy syndrome	0.000104	0.000578	CcSEcCtD
Ciclesonide—CYP2D6—central nervous system—epilepsy syndrome	0.000104	0.0128	CbGeAlD
Ciclesonide—Hypertension—Valproic Acid—epilepsy syndrome	0.000104	0.000577	CcSEcCtD
Ciclesonide—CYP3A4—Xenobiotics—CYP2C19—epilepsy syndrome	0.000104	0.00525	CbGpPWpGaD
Ciclesonide—Immune system disorder—Gabapentin—epilepsy syndrome	0.000104	0.000575	CcSEcCtD
Ciclesonide—Prednisone—NR3C1—epilepsy syndrome	0.000104	0.0256	CrCbGaD
Ciclesonide—Headache—Propofol—epilepsy syndrome	0.000104	0.000575	CcSEcCtD
Ciclesonide—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000104	0.000574	CcSEcCtD
Ciclesonide—Asthenia—Felbamate—epilepsy syndrome	0.000103	0.00057	CcSEcCtD
Ciclesonide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000103	0.000569	CcSEcCtD
Ciclesonide—Chest pain—Valproic Acid—epilepsy syndrome	0.000103	0.000569	CcSEcCtD
Ciclesonide—Rash—Midazolam—epilepsy syndrome	0.000102	0.000566	CcSEcCtD
Ciclesonide—Dizziness—Fosphenytoin—epilepsy syndrome	0.000102	0.000566	CcSEcCtD
Ciclesonide—Dermatitis—Midazolam—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Ciclesonide—CYP2D6—cerebellum—epilepsy syndrome	0.000102	0.0126	CbGeAlD
Ciclesonide—Urticaria—Carbamazepine—epilepsy syndrome	0.000102	0.000565	CcSEcCtD
Ciclesonide—Epistaxis—Topiramate—epilepsy syndrome	0.000102	0.000563	CcSEcCtD
Ciclesonide—Headache—Midazolam—epilepsy syndrome	0.000102	0.000562	CcSEcCtD
Ciclesonide—Sinusitis—Topiramate—epilepsy syndrome	0.000101	0.00056	CcSEcCtD
Ciclesonide—Rash—Levetiracetam—epilepsy syndrome	0.000101	0.000559	CcSEcCtD
Ciclesonide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000101	0.000558	CcSEcCtD
Ciclesonide—Asthenia—Zonisamide—epilepsy syndrome	0.000101	0.000558	CcSEcCtD
Ciclesonide—Dry mouth—Valproic Acid—epilepsy syndrome	0.000101	0.000557	CcSEcCtD
Ciclesonide—Headache—Levetiracetam—epilepsy syndrome	0.0001	0.000555	CcSEcCtD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2C19—epilepsy syndrome	0.0001	0.00505	CbGpPWpGaD
Ciclesonide—Angioedema—Pregabalin—epilepsy syndrome	9.99e-05	0.000552	CcSEcCtD
Ciclesonide—Dizziness—Vigabatrin—epilepsy syndrome	9.97e-05	0.000551	CcSEcCtD
Ciclesonide—Urticaria—Lamotrigine—epilepsy syndrome	9.86e-05	0.000546	CcSEcCtD
Ciclesonide—Nausea—Propofol—epilepsy syndrome	9.85e-05	0.000545	CcSEcCtD
Ciclesonide—Dysgeusia—Gabapentin—epilepsy syndrome	9.82e-05	0.000543	CcSEcCtD
Ciclesonide—Dizziness—Diazepam—epilepsy syndrome	9.81e-05	0.000543	CcSEcCtD
Ciclesonide—Infection—Valproic Acid—epilepsy syndrome	9.8e-05	0.000542	CcSEcCtD
Ciclesonide—Rash—Fosphenytoin—epilepsy syndrome	9.75e-05	0.000539	CcSEcCtD
Ciclesonide—Dermatitis—Fosphenytoin—epilepsy syndrome	9.74e-05	0.000539	CcSEcCtD
Ciclesonide—Haemoglobin—Topiramate—epilepsy syndrome	9.74e-05	0.000539	CcSEcCtD
Ciclesonide—Asthenia—Clonazepam—epilepsy syndrome	9.72e-05	0.000538	CcSEcCtD
Ciclesonide—Rhinitis—Topiramate—epilepsy syndrome	9.71e-05	0.000537	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—epilepsy syndrome	9.71e-05	0.00488	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—GABRA1—epilepsy syndrome	9.71e-05	0.00488	CbGpPWpGaD
Ciclesonide—Back pain—Gabapentin—epilepsy syndrome	9.7e-05	0.000536	CcSEcCtD
Ciclesonide—Headache—Fosphenytoin—epilepsy syndrome	9.69e-05	0.000536	CcSEcCtD
Ciclesonide—Haemorrhage—Topiramate—epilepsy syndrome	9.69e-05	0.000536	CcSEcCtD
Ciclesonide—Palpitations—Pregabalin—epilepsy syndrome	9.66e-05	0.000534	CcSEcCtD
Ciclesonide—Asthenia—Phenytoin—epilepsy syndrome	9.66e-05	0.000534	CcSEcCtD
Ciclesonide—Nausea—Midazolam—epilepsy syndrome	9.64e-05	0.000533	CcSEcCtD
Ciclesonide—Pharyngitis—Topiramate—epilepsy syndrome	9.61e-05	0.000532	CcSEcCtD
Ciclesonide—Asthenia—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000531	CcSEcCtD
Ciclesonide—Prednisolone—NR3C1—epilepsy syndrome	9.58e-05	0.0236	CrCbGaD
Ciclesonide—Cough—Pregabalin—epilepsy syndrome	9.54e-05	0.000528	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—epilepsy syndrome	9.53e-05	0.00479	CbGpPWpGaD
Ciclesonide—Nausea—Levetiracetam—epilepsy syndrome	9.52e-05	0.000526	CcSEcCtD
Ciclesonide—Rash—Vigabatrin—epilepsy syndrome	9.51e-05	0.000526	CcSEcCtD
Ciclesonide—Dizziness—Felbamate—epilepsy syndrome	9.5e-05	0.000525	CcSEcCtD
Ciclesonide—Dermatitis—Vigabatrin—epilepsy syndrome	9.5e-05	0.000525	CcSEcCtD
Ciclesonide—Prednisone—CYP2C19—epilepsy syndrome	9.48e-05	0.0234	CrCbGaD
Ciclesonide—Headache—Vigabatrin—epilepsy syndrome	9.44e-05	0.000522	CcSEcCtD
Ciclesonide—Hypertension—Pregabalin—epilepsy syndrome	9.44e-05	0.000522	CcSEcCtD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—epilepsy syndrome	9.38e-05	0.00472	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2D6—epilepsy syndrome	9.36e-05	0.00471	CbGpPWpGaD
Ciclesonide—Rash—Diazepam—epilepsy syndrome	9.36e-05	0.000518	CcSEcCtD
Ciclesonide—Dermatitis—Diazepam—epilepsy syndrome	9.35e-05	0.000517	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—epilepsy syndrome	9.34e-05	0.0047	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUNB—epilepsy syndrome	9.32e-05	0.00469	CbGpPWpGaD
Ciclesonide—Chest pain—Pregabalin—epilepsy syndrome	9.31e-05	0.000515	CcSEcCtD
Ciclesonide—Arthralgia—Pregabalin—epilepsy syndrome	9.31e-05	0.000515	CcSEcCtD
Ciclesonide—Dizziness—Zonisamide—epilepsy syndrome	9.3e-05	0.000514	CcSEcCtD
Ciclesonide—Headache—Diazepam—epilepsy syndrome	9.3e-05	0.000514	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—AVP—epilepsy syndrome	9.28e-05	0.00467	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TH—epilepsy syndrome	9.25e-05	0.00465	CbGpPWpGaD
Ciclesonide—Asthenia—Carbamazepine—epilepsy syndrome	9.22e-05	0.00051	CcSEcCtD
Ciclesonide—Nausea—Fosphenytoin—epilepsy syndrome	9.19e-05	0.000508	CcSEcCtD
Ciclesonide—Angioedema—Gabapentin—epilepsy syndrome	9.16e-05	0.000507	CcSEcCtD
Ciclesonide—Dry mouth—Pregabalin—epilepsy syndrome	9.1e-05	0.000503	CcSEcCtD
Ciclesonide—Rash—Felbamate—epilepsy syndrome	9.06e-05	0.000501	CcSEcCtD
Ciclesonide—Dermatitis—Felbamate—epilepsy syndrome	9.05e-05	0.0005	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—epilepsy syndrome	9.03e-05	0.00454	CbGpPWpGaD
Ciclesonide—CYP3A4—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	9e-05	0.00453	CbGpPWpGaD
Ciclesonide—Headache—Felbamate—epilepsy syndrome	9e-05	0.000498	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.99e-05	0.000497	CcSEcCtD
Ciclesonide—Dizziness—Clonazepam—epilepsy syndrome	8.96e-05	0.000496	CcSEcCtD
Ciclesonide—Nausea—Vigabatrin—epilepsy syndrome	8.95e-05	0.000495	CcSEcCtD
Ciclesonide—Asthenia—Lamotrigine—epilepsy syndrome	8.91e-05	0.000493	CcSEcCtD
Ciclesonide—Dizziness—Phenytoin—epilepsy syndrome	8.9e-05	0.000492	CcSEcCtD
Ciclesonide—Rash—Zonisamide—epilepsy syndrome	8.87e-05	0.00049	CcSEcCtD
Ciclesonide—Infection—Pregabalin—epilepsy syndrome	8.86e-05	0.00049	CcSEcCtD
Ciclesonide—Palpitations—Gabapentin—epilepsy syndrome	8.86e-05	0.00049	CcSEcCtD
Ciclesonide—Dermatitis—Zonisamide—epilepsy syndrome	8.86e-05	0.00049	CcSEcCtD
Ciclesonide—Dizziness—Oxcarbazepine—epilepsy syndrome	8.85e-05	0.00049	CcSEcCtD
Ciclesonide—Nausea—Diazepam—epilepsy syndrome	8.82e-05	0.000488	CcSEcCtD
Ciclesonide—Headache—Zonisamide—epilepsy syndrome	8.81e-05	0.000487	CcSEcCtD
Ciclesonide—Dyspnoea—Valproic Acid—epilepsy syndrome	8.8e-05	0.000487	CcSEcCtD
Ciclesonide—Immune system disorder—Topiramate—epilepsy syndrome	8.75e-05	0.000484	CcSEcCtD
Ciclesonide—Cough—Gabapentin—epilepsy syndrome	8.75e-05	0.000484	CcSEcCtD
Ciclesonide—Mediastinal disorder—Topiramate—epilepsy syndrome	8.73e-05	0.000483	CcSEcCtD
Ciclesonide—Dyspepsia—Valproic Acid—epilepsy syndrome	8.69e-05	0.00048	CcSEcCtD
Ciclesonide—Hypertension—Gabapentin—epilepsy syndrome	8.65e-05	0.000479	CcSEcCtD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	8.65e-05	0.00435	CbGpPWpGaD
Ciclesonide—Rash—Clonazepam—epilepsy syndrome	8.54e-05	0.000473	CcSEcCtD
Ciclesonide—Dermatitis—Clonazepam—epilepsy syndrome	8.54e-05	0.000472	CcSEcCtD
Ciclesonide—CYP2D6—Metapathway biotransformation—KCNAB2—epilepsy syndrome	8.53e-05	0.00429	CbGpPWpGaD
Ciclesonide—Arthralgia—Gabapentin—epilepsy syndrome	8.53e-05	0.000472	CcSEcCtD
Ciclesonide—Chest pain—Gabapentin—epilepsy syndrome	8.53e-05	0.000472	CcSEcCtD
Ciclesonide—Nausea—Felbamate—epilepsy syndrome	8.53e-05	0.000472	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.52e-05	0.000471	CcSEcCtD
Ciclesonide—Fatigue—Valproic Acid—epilepsy syndrome	8.51e-05	0.000471	CcSEcCtD
Ciclesonide—Hydrocortisone—ABCG2—epilepsy syndrome	8.5e-05	0.0209	CrCbGaD
Ciclesonide—Dizziness—Carbamazepine—epilepsy syndrome	8.5e-05	0.00047	CcSEcCtD
Ciclesonide—NR3C1—Circadian Clock—MEF2C—epilepsy syndrome	8.49e-05	0.00427	CbGpPWpGaD
Ciclesonide—Headache—Clonazepam—epilepsy syndrome	8.49e-05	0.00047	CcSEcCtD
Ciclesonide—Rash—Phenytoin—epilepsy syndrome	8.49e-05	0.000469	CcSEcCtD
Ciclesonide—Dermatitis—Phenytoin—epilepsy syndrome	8.48e-05	0.000469	CcSEcCtD
Ciclesonide—Rash—Oxcarbazepine—epilepsy syndrome	8.44e-05	0.000467	CcSEcCtD
Ciclesonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.43e-05	0.000467	CcSEcCtD
Ciclesonide—Headache—Phenytoin—epilepsy syndrome	8.43e-05	0.000466	CcSEcCtD
Ciclesonide—Headache—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000464	CcSEcCtD
Ciclesonide—Nausea—Zonisamide—epilepsy syndrome	8.35e-05	0.000462	CcSEcCtD
Ciclesonide—Dry mouth—Gabapentin—epilepsy syndrome	8.35e-05	0.000462	CcSEcCtD
Ciclesonide—CYP2D6—brain—epilepsy syndrome	8.29e-05	0.0102	CbGeAlD
Ciclesonide—Dysgeusia—Topiramate—epilepsy syndrome	8.26e-05	0.000457	CcSEcCtD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—epilepsy syndrome	8.24e-05	0.00414	CbGpPWpGaD
Ciclesonide—Dizziness—Lamotrigine—epilepsy syndrome	8.21e-05	0.000454	CcSEcCtD
Ciclesonide—Back pain—Topiramate—epilepsy syndrome	8.16e-05	0.000451	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.13e-05	0.00045	CcSEcCtD
Ciclesonide—Infection—Gabapentin—epilepsy syndrome	8.13e-05	0.000449	CcSEcCtD
Ciclesonide—Rash—Carbamazepine—epilepsy syndrome	8.1e-05	0.000448	CcSEcCtD
Ciclesonide—Dermatitis—Carbamazepine—epilepsy syndrome	8.09e-05	0.000448	CcSEcCtD
Ciclesonide—Nausea—Clonazepam—epilepsy syndrome	8.05e-05	0.000445	CcSEcCtD
Ciclesonide—Headache—Carbamazepine—epilepsy syndrome	8.05e-05	0.000445	CcSEcCtD
Ciclesonide—Nausea—Phenytoin—epilepsy syndrome	8e-05	0.000442	CcSEcCtD
Ciclesonide—Dyspnoea—Pregabalin—epilepsy syndrome	7.95e-05	0.00044	CcSEcCtD
Ciclesonide—Nausea—Oxcarbazepine—epilepsy syndrome	7.95e-05	0.00044	CcSEcCtD
Ciclesonide—Urticaria—Valproic Acid—epilepsy syndrome	7.84e-05	0.000434	CcSEcCtD
Ciclesonide—Rash—Lamotrigine—epilepsy syndrome	7.83e-05	0.000433	CcSEcCtD
Ciclesonide—Dermatitis—Lamotrigine—epilepsy syndrome	7.82e-05	0.000433	CcSEcCtD
Ciclesonide—Headache—Lamotrigine—epilepsy syndrome	7.78e-05	0.00043	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.7e-05	0.000426	CcSEcCtD
Ciclesonide—Fatigue—Pregabalin—epilepsy syndrome	7.69e-05	0.000425	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AQP4—epilepsy syndrome	7.67e-05	0.00386	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SLC1A3—epilepsy syndrome	7.67e-05	0.00386	CbGpPWpGaD
Ciclesonide—Nausea—Carbamazepine—epilepsy syndrome	7.63e-05	0.000422	CcSEcCtD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	7.61e-05	0.00383	CbGpPWpGaD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	7.6e-05	0.00382	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—UBE3A—epilepsy syndrome	7.57e-05	0.00381	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.45e-05	0.000412	CcSEcCtD
Ciclesonide—Palpitations—Topiramate—epilepsy syndrome	7.45e-05	0.000412	CcSEcCtD
Ciclesonide—Nausea—Lamotrigine—epilepsy syndrome	7.38e-05	0.000408	CcSEcCtD
Ciclesonide—Cough—Topiramate—epilepsy syndrome	7.36e-05	0.000407	CcSEcCtD
Ciclesonide—Hydrocortisone—NR3C1—epilepsy syndrome	7.33e-05	0.0181	CrCbGaD
Ciclesonide—Dyspnoea—Gabapentin—epilepsy syndrome	7.29e-05	0.000403	CcSEcCtD
Ciclesonide—Hypertension—Topiramate—epilepsy syndrome	7.28e-05	0.000403	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—BMP4—epilepsy syndrome	7.24e-05	0.00364	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRM2—epilepsy syndrome	7.22e-05	0.00363	CbGpPWpGaD
Ciclesonide—Dyspepsia—Gabapentin—epilepsy syndrome	7.2e-05	0.000398	CcSEcCtD
Ciclesonide—Arthralgia—Topiramate—epilepsy syndrome	7.18e-05	0.000397	CcSEcCtD
Ciclesonide—Chest pain—Topiramate—epilepsy syndrome	7.18e-05	0.000397	CcSEcCtD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	7.17e-05	0.0036	CbGpPWpGaD
Ciclesonide—Urticaria—Pregabalin—epilepsy syndrome	7.09e-05	0.000392	CcSEcCtD
Ciclesonide—Asthenia—Valproic Acid—epilepsy syndrome	7.08e-05	0.000392	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.06e-05	0.000391	CcSEcCtD
Ciclesonide—Fatigue—Gabapentin—epilepsy syndrome	7.05e-05	0.00039	CcSEcCtD
Ciclesonide—Dry mouth—Topiramate—epilepsy syndrome	7.02e-05	0.000388	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—epilepsy syndrome	6.91e-05	0.00348	CbGpPWpGaD
Ciclesonide—Infection—Topiramate—epilepsy syndrome	6.84e-05	0.000378	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—epilepsy syndrome	6.72e-05	0.00338	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	6.63e-05	0.00333	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	6.59e-05	0.00331	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—epilepsy syndrome	6.58e-05	0.00331	CbGpPWpGaD
Ciclesonide—Methylprednisolone—ABCB1—epilepsy syndrome	6.56e-05	0.0162	CrCbGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	6.54e-05	0.00329	CbGpPWpGaD
Ciclesonide—Dizziness—Valproic Acid—epilepsy syndrome	6.53e-05	0.000361	CcSEcCtD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	6.5e-05	0.00327	CbGpPWpGaD
Ciclesonide—Urticaria—Gabapentin—epilepsy syndrome	6.5e-05	0.000359	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—epilepsy syndrome	6.48e-05	0.00326	CbGpPWpGaD
Ciclesonide—Asthenia—Pregabalin—epilepsy syndrome	6.4e-05	0.000354	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.27e-05	0.000347	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—epilepsy syndrome	6.23e-05	0.00313	CbGpPWpGaD
Ciclesonide—Rash—Valproic Acid—epilepsy syndrome	6.22e-05	0.000344	CcSEcCtD
Ciclesonide—Dermatitis—Valproic Acid—epilepsy syndrome	6.22e-05	0.000344	CcSEcCtD
Ciclesonide—Headache—Valproic Acid—epilepsy syndrome	6.18e-05	0.000342	CcSEcCtD
Ciclesonide—Dyspnoea—Topiramate—epilepsy syndrome	6.14e-05	0.000339	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—epilepsy syndrome	6.07e-05	0.00305	CbGpPWpGaD
Ciclesonide—Dyspepsia—Topiramate—epilepsy syndrome	6.06e-05	0.000335	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—AGT—epilepsy syndrome	6.04e-05	0.00304	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PLAU—epilepsy syndrome	6.01e-05	0.00302	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.94e-05	0.000329	CcSEcCtD
Ciclesonide—Fatigue—Topiramate—epilepsy syndrome	5.93e-05	0.000328	CcSEcCtD
Ciclesonide—Dizziness—Pregabalin—epilepsy syndrome	5.9e-05	0.000326	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—epilepsy syndrome	5.88e-05	0.00296	CbGpPWpGaD
Ciclesonide—Asthenia—Gabapentin—epilepsy syndrome	5.87e-05	0.000325	CcSEcCtD
Ciclesonide—Nausea—Valproic Acid—epilepsy syndrome	5.86e-05	0.000324	CcSEcCtD
Ciclesonide—Rash—Pregabalin—epilepsy syndrome	5.62e-05	0.000311	CcSEcCtD
Ciclesonide—Dermatitis—Pregabalin—epilepsy syndrome	5.62e-05	0.000311	CcSEcCtD
Ciclesonide—Headache—Pregabalin—epilepsy syndrome	5.59e-05	0.000309	CcSEcCtD
Ciclesonide—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	5.58e-05	0.00281	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—epilepsy syndrome	5.47e-05	0.00275	CbGpPWpGaD
Ciclesonide—Urticaria—Topiramate—epilepsy syndrome	5.47e-05	0.000302	CcSEcCtD
Ciclesonide—Dizziness—Gabapentin—epilepsy syndrome	5.41e-05	0.000299	CcSEcCtD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	5.37e-05	0.0027	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	5.34e-05	0.00269	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	5.32e-05	0.00268	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SST—epilepsy syndrome	5.32e-05	0.00268	CbGpPWpGaD
Ciclesonide—Nausea—Pregabalin—epilepsy syndrome	5.3e-05	0.000293	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	5.3e-05	0.00266	CbGpPWpGaD
Ciclesonide—Prednisone—ALB—epilepsy syndrome	5.26e-05	0.013	CrCbGaD
Ciclesonide—Rash—Gabapentin—epilepsy syndrome	5.16e-05	0.000285	CcSEcCtD
Ciclesonide—Dermatitis—Gabapentin—epilepsy syndrome	5.15e-05	0.000285	CcSEcCtD
Ciclesonide—Headache—Gabapentin—epilepsy syndrome	5.12e-05	0.000283	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—FOS—epilepsy syndrome	5.09e-05	0.00256	CbGpPWpGaD
Ciclesonide—Prednisone—ABCB1—epilepsy syndrome	5.02e-05	0.0124	CrCbGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCL2—epilepsy syndrome	4.98e-05	0.0025	CbGpPWpGaD
Ciclesonide—Asthenia—Topiramate—epilepsy syndrome	4.94e-05	0.000273	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TH—epilepsy syndrome	4.87e-05	0.00245	CbGpPWpGaD
Ciclesonide—Nausea—Gabapentin—epilepsy syndrome	4.86e-05	0.000269	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—SOCS3—epilepsy syndrome	4.83e-05	0.00243	CbGpPWpGaD
Ciclesonide—Prednisolone—ABCB1—epilepsy syndrome	4.62e-05	0.0114	CrCbGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.59e-05	0.00231	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—JUN—epilepsy syndrome	4.57e-05	0.0023	CbGpPWpGaD
Ciclesonide—Dizziness—Topiramate—epilepsy syndrome	4.55e-05	0.000252	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—epilepsy syndrome	4.53e-05	0.00228	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—epilepsy syndrome	4.49e-05	0.00226	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—epilepsy syndrome	4.48e-05	0.00225	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	4.37e-05	0.0022	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	4.36e-05	0.00219	CbGpPWpGaD
Ciclesonide—Rash—Topiramate—epilepsy syndrome	4.34e-05	0.00024	CcSEcCtD
Ciclesonide—Dermatitis—Topiramate—epilepsy syndrome	4.34e-05	0.00024	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.33e-05	0.00218	CbGpPWpGaD
Ciclesonide—Headache—Topiramate—epilepsy syndrome	4.31e-05	0.000238	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.31e-05	0.00217	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.28e-05	0.00215	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—MEF2C—epilepsy syndrome	4.27e-05	0.00215	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.25e-05	0.00214	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SRC—epilepsy syndrome	4.1e-05	0.00206	CbGpPWpGaD
Ciclesonide—Nausea—Topiramate—epilepsy syndrome	4.09e-05	0.000226	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	4.03e-05	0.00203	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	3.97e-05	0.002	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	3.89e-05	0.00195	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	3.84e-05	0.00193	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	3.81e-05	0.00192	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—WARS—epilepsy syndrome	3.76e-05	0.00189	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	3.69e-05	0.00185	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—AGT—epilepsy syndrome	3.68e-05	0.00185	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—epilepsy syndrome	3.68e-05	0.00185	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—JUN—epilepsy syndrome	3.66e-05	0.00184	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	3.56e-05	0.00179	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—epilepsy syndrome	3.56e-05	0.00179	CbGpPWpGaD
Ciclesonide—Hydrocortisone—ABCB1—epilepsy syndrome	3.54e-05	0.00872	CrCbGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.53e-05	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	3.52e-05	0.00177	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.51e-05	0.00177	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.49e-05	0.00176	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6ST—epilepsy syndrome	3.39e-05	0.0017	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	3.35e-05	0.00169	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—epilepsy syndrome	3.25e-05	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—epilepsy syndrome	3.22e-05	0.00162	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.15e-05	0.00158	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	2.96e-05	0.00149	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.91e-05	0.00146	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	2.85e-05	0.00144	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	2.85e-05	0.00143	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	2.84e-05	0.00143	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.82e-05	0.00142	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.8e-05	0.00141	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.36e-05	0.00119	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	2.28e-05	0.00115	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	2.07e-05	0.00104	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	2.06e-05	0.00104	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	1.99e-05	0.001	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	1.98e-05	0.000998	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA13—epilepsy syndrome	1.95e-05	0.000982	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	1.93e-05	0.000969	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	1.9e-05	0.000958	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	1.87e-05	0.000939	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	1.85e-05	0.000933	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.84e-05	0.000926	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.83e-05	0.00092	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	1.81e-05	0.000912	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	1.8e-05	0.000904	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	1.78e-05	0.000894	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	1.68e-05	0.000846	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.67e-05	0.000842	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	1.67e-05	0.000839	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.65e-05	0.00083	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	1.65e-05	0.000828	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.54e-05	0.000776	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADK—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—FAR1—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PDXK—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CERS1—epilepsy syndrome	1.48e-05	0.000744	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.44e-05	0.000725	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.35e-05	0.000681	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.35e-05	0.000681	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.35e-05	0.000681	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.35e-05	0.000681	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.28e-05	0.000642	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.26e-05	0.000633	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.26e-05	0.000633	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.25e-05	0.000631	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	1.24e-05	0.000624	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	1.2e-05	0.000602	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.18e-05	0.000595	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.12e-05	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.12e-05	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.12e-05	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.12e-05	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.12e-05	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.03e-05	0.000516	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.03e-05	0.000516	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.03e-05	0.000516	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	9.99e-06	0.000502	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	9.87e-06	0.000497	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.67e-06	0.000487	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	9.54e-06	0.00048	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	9.54e-06	0.00048	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.97e-06	0.000451	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.85e-06	0.000445	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.85e-06	0.000445	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.85e-06	0.000445	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.85e-06	0.000445	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	8.72e-06	0.000439	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	8.5e-06	0.000427	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	8.5e-06	0.000427	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.23e-06	0.000414	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.23e-06	0.000414	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.2e-06	0.000412	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	8.11e-06	0.000408	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	8.11e-06	0.000408	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	8.04e-06	0.000404	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.93e-06	0.000399	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	7.93e-06	0.000399	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	7.77e-06	0.000391	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.73e-06	0.000389	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	7.62e-06	0.000383	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	7.51e-06	0.000378	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	7.48e-06	0.000376	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.33e-06	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.33e-06	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.33e-06	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.33e-06	0.000369	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.33e-06	0.000369	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	7.25e-06	0.000365	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	7e-06	0.000352	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.79e-06	0.000342	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.71e-06	0.000337	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.71e-06	0.000337	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.71e-06	0.000337	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.46e-06	0.000325	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.23e-06	0.000314	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.23e-06	0.000314	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	6.14e-06	0.000309	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	6.14e-06	0.000309	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.86e-06	0.000295	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.7e-06	0.000287	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.56e-06	0.000279	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.56e-06	0.000279	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.3e-06	0.000267	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.3e-06	0.000267	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.19e-06	0.000261	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.08e-06	0.000256	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	5.01e-06	0.000252	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.98e-06	0.000251	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.89e-06	0.000246	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.88e-06	0.000246	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.85e-06	0.000244	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.58e-06	0.00023	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.44e-06	0.000223	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.17e-06	0.00021	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4.15e-06	0.000209	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.02e-06	0.000202	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.02e-06	0.000202	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.96e-06	0.000199	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.92e-06	0.000197	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TH—epilepsy syndrome	3.9e-06	0.000196	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.27e-06	0.000165	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.26e-06	0.000164	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.21e-06	0.000162	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.19e-06	0.000161	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.17e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.13e-06	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.91e-06	0.000146	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.86e-06	0.000144	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.73e-06	0.000137	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.71e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.59e-06	0.00013	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.56e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.55e-06	0.000128	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.55e-06	0.000128	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.5e-06	0.000126	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	2.18e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.14e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.13e-06	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.1e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.04e-06	0.000103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.96e-06	9.84e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.9e-06	9.56e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	8.6e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.67e-06	8.38e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.63e-06	8.21e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.4e-06	7.05e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.28e-06	6.43e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	5.63e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	8.6e-07	4.32e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.62e-07	2.83e-05	CbGpPWpGaD
